Following important cannabis news articles every day can be a real burn-out, we know. That’s why the Emerald rolls up a chronicle of the headiest news hits, and passes them to you at the end of each week. We Bring You: The Dime. Detroit Residents Vote on Legalizing Psychedelics On Tuesday, November 2nd, residents of Detroit will vote on Proposal E to decriminalize … [Read more...] about The Dime: 10/29/2021
psychedelics
The Dime: 6/4/2021
Following important cannabis news articles every day can be a real burn-out, we know. That’s why the Emerald rolls up a chronicle of the headiest news hits, and passes them to you at the end of each week. We Bring You: The Dime. California Senate Approves Bill to Decriminalize Psychedelics This week, California lawmakers inched closer to ending the War on Drugs. … [Read more...] about The Dime: 6/4/2021
MDMA Inches Toward FDA Approval for the Treatment of PTSD
The drug 3,4-Methylenedioxymethamphetamine, also known as MDMA or ”Molly,” is a schedule I drug with no current medical use, according to the U.S. Drug Enforcement Administration (DEA). However, a recent study conducted by Jennifer M. Mitchell, Michael Bogenschutz and 36 other pioneers in therapeutic studies, stands to challenge that classification. More specifically, the … [Read more...] about MDMA Inches Toward FDA Approval for the Treatment of PTSD
The Future of Medicine: Psilocybin, MDMA and Cannabis Treatments
Researchers have used illicit substances like psilocybin, MDMA and cannabis in studies for decades to test their effectiveness in treating psychiatric disorders. Now, those studies are laying the groundwork for clinical trials that enable researchers to find new, effective treatments. What is Psilocybin? Psilocybin is a natural hallucinogenic substance in mushrooms. This … [Read more...] about The Future of Medicine: Psilocybin, MDMA and Cannabis Treatments
Emerald speaks with DoubleBlind Magazine
Emerald Media interviews Shelby Hartman, co-founder of psychedelic media company, DoubleBlind Magazine. Hartman joins us from L.A. where she discusses the first time she tried mushrooms, "the mystical experience," and research on psilocybin for mental health. … [Read more...] about Emerald speaks with DoubleBlind Magazine